Xiaoyan Y. Luo

Ministry Of Education Key Laboratory Of Child Development And Disorders, Chongqing Key Laboratory Of Child Infection And Immunity
Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Risk Factors for Progression to Chronicity or Recurrent Episodes in Pediatric Acute Urticaria: A 1-Year Cohort Study.

Risk Factors for Progression to Chronicity or Recurrent Episodes in Pediatric Acute Urticaria: A 1-Year Cohort Study.

Journal: Journal of asthma and allergy

Published: May 29, 2026

A novel JAK1 mutation identified in a patient with severe atopic dermatitis phenotype: Mechanistic insights and IL-4Rα targeted therapy.

A novel JAK1 mutation identified in a patient with severe atopic dermatitis phenotype: Mechanistic insights and IL-4Rα targeted therapy.

Journal: Clinical immunology (Orlando, Fla.)

Published: May 10, 2026

Inflammation-triggered nanodrug delivery microneedles targeting pathogenic COX2+ endothelial cell-mediated glycocalyx degradation to ameliorate psoriasis.

Inflammation-triggered nanodrug delivery microneedles targeting pathogenic COX2+ endothelial cell-mediated glycocalyx degradation to ameliorate psoriasis.

Journal: Biomaterials

Published: March 09, 2026

Risk factors associated with treatment failure in peritoneal dialysis-associated peritonitis.

Risk factors associated with treatment failure in peritoneal dialysis-associated peritonitis.

Journal: Experimental and therapeutic medicine

Published: January 28, 2026

Associations of the first trimester exposure to PM2.5 components and offspring atopic dermatitis: Effect modification by systemic low-grade inflammation.

Associations of the first trimester exposure to PM2.5 components and offspring atopic dermatitis: Effect modification by systemic low-grade inflammation.

Journal: Ecotoxicology and environmental safety

Published: December 21, 2025

Acid-Stable Ruthenium-Based Solid Solution for Oxygen Evolution in Proton Exchange Membrane Electrolyzers.

Acid-Stable Ruthenium-Based Solid Solution for Oxygen Evolution in Proton Exchange Membrane Electrolyzers.

Journal: Angewandte Chemie (International ed. in English)

Published: October 10, 2025

Dupilumab in Children Under 6 Years With Moderate-to-Severe Atopic Dermatitis: A 16-Week Real-World Prospective Study on Efficacy, Safety, and Local-Systemic Immune Responses.

Dupilumab in Children Under 6 Years With Moderate-to-Severe Atopic Dermatitis: A 16-Week Real-World Prospective Study on Efficacy, Safety, and Local-Systemic Immune Responses.

Journal: Allergy

Published: June 06, 2025

Trajectories of childhood atopic dermatitis and their association with attention-deficit hyperactivity disorder.

Trajectories of childhood atopic dermatitis and their association with attention-deficit hyperactivity disorder.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: May 30, 2025

Defective K2Ti8O17 Nanorod Supports Enable Stable High-Current-Density Acidic Water Electrolysis via Confinement-Engineered IrOx.

Defective K2Ti8O17 Nanorod Supports Enable Stable High-Current-Density Acidic Water Electrolysis via Confinement-Engineered IrOx.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: April 28, 2025

Response to Comments on The Association of Inflammatory Indexes Derived From Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis [Response to Letter].

Response to Comments on The Association of Inflammatory Indexes Derived From Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis [Response to Letter].

Journal: Journal of inflammation research

Published: February 20, 2025

Projected Epidemiology of Atopic Dermatitis in Children From 2022 to 2050: Findings From the Global Burden of Disease Study 2021.

Projected Epidemiology of Atopic Dermatitis in Children From 2022 to 2050: Findings From the Global Burden of Disease Study 2021.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: October 31, 2024

The Association of Inflammatory Indexes Derived from Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis.

The Association of Inflammatory Indexes Derived from Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis.

Journal: Journal of inflammation research

Published: October 20, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026